Download PDF
CC BY-NC-ND 4.0 · Journal of Social Health and Diabetes 2020; 8(01): 003-007
DOI: 10.1055/s-0040-1716439
Review Article

Managing Diabetes in the COVID-19 Era: Focus on COVID-19 Safe Clinics, Telemedicine, and Diabetes Self-Management

Rajan Palui
1   Department of Endocrinology, The Mission Hospital, Durgapur, West Bengal, India
,
Subhodip Pramanik
2   Department of Endocrinology, Neotia Getwel, Siliguri, West Bengal, India
,
Arindam Ray
3   Department of General Medicine, College of Medicine and Sagore Dutta Hospital, Kolkata, West Bengal, India
,
Uttio Gupta
4   Department of Endocrinology, Medical Super Speciality Hospital, Kolkata, West Bengal, India
,
Sattik Siddhanta
5   Department of General Medicine, IPGMER, Kolkata, West Bengal, India
,
Deep Dutta
6   Department of Endocrinology, CEDAR Superspeciality Clinics, New Delhi, India
› Author Affiliations Funding None.
› Further Information
   Permissions and Reprints

Abstract

Novel coronavirus disease 2019 is a dreaded pandemic that is going to persist, and diabetic people with poor glycemic control are at high risk of complications and death from it. Social distancing being the only way to prevent infection spread, it is very difficult to continue usual clinic-based diabetes care. So, in this review, we focus to discuss safe clinic practice recommendations, scope of telemedicine in care of follow-up patients, and diabetes self-management that every individual with diabetes needs to follow. These issues will be of utmost important as we need to understand and implement personal and social hygiene in a better way even in post lockdown period.

Keywords

coronavirus - lockdown - telemedicine


Publication History

Article published online:
14 September 2020

© 2020. Novo Nordisk Education Foundation. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention [published online ahead of print, 2020 Feb 24]. JAMA 2020; 323 (13) 1239-1242
    CrossrefPubMedGoogle Scholar
  • 2 Yang X, Yu Y, Xu J. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8 (05) 475-481
    CrossrefPubMedGoogle Scholar
  • 3 Guan WJ, Ni ZY, Hu Y. et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720
    CrossrefPubMedGoogle Scholar
  • 4 Telemedicine Practice Guidelines. https://www.mohfw.gov.in/pdf/Telemedicine.pdf. Accessed July 31, 2020
  • 5 COVID-19 and diabetes. https://www.idf.org/aboutdiabetes/what-is-diabetes/covid-19-and-diabetes.html . Accessed July 31, 2020
  • 6 Healthy nutrition and home-based exercise. https://www.idf.org/aboutdiabetes/what-is-diabetes/covid-19-and-diabetes/home-based-exercise.html. Accessed July 31, 2020
  • 7 How to manage diabetes during an illness? https://www.idf.org/component/attachments/?task=download&id=2155:IDFE-Sick-day-management. Accessed July 31, 2020